Clinical Trials Browser

INDUSTRY × Epilepsy × 1 year × Clear all

NCT05626634 2025-12-03

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Phase 2 Completed

CDKL5 deficiency disorder, Epilepsy, Epilepsies, Myoclonic, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT04106219 2025-07-23

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Phase 1 Active not recruiting

Epilepsy, Neuroblastoma

NCT03731455 2025-07-17

WIN

Phase NA Completed

Epilepsy

NCT02392078 2025-04-24

LAANTERN

1,153 enrolled 15 charts

Brain Neoplasms, Epilepsy, Movement Disorders, Disease Progression